Louis Dias joined Medtronic Diabetes as our Chief Patient Officer in July 2015. Louis is responsible for putting patients’ voice at the center of all our business processes – from product development to customer service and everything in between. He brings more than 20 years of experience in customer insights, marketing strategy and innovation for companies like Johnson & Johnson Vision Care and Procter & Gamble.
Originally from Portugal, Louis earned a B.S. in Chemical Engineering from the University of Houston. He is fluent in French, German, Portuguese and Spanish. He loves sardines, sports (especially soccer), outdoor activities and spending time with his beautiful family – he and his wife Heather are proud parents of a son and two daughters.
The Big News I have been personally touched by the inspiring stories of children and their families. Juggling school tests and carb counts. Middle of the night finger pokes. Highs and lows, physically and emotionally. And while my three children don’t have diabetes, I know the feeling of wanting the very best for them (to […]Read More »
In March, we announced FDA approval of the world’s first Smart1 CGM, the Guardian Connect system. This all new continuous glucose monitor is specifically designed to provide valuable insights – right on your smartphone – so you can take action2 against highs and lows. If you inject insulin or manage diabetes with oral medication, I’m excited […]Read More »
A new year means new beginnings. I want to take this time to thank you for your patience with us over the last few months and share some very positive updates with you. Product Supply Update As many of you know, an earlier-than-expected approval of the MiniMed™ 670G system with SmartGuard™ technology, unprecedented demand for […]Read More »
This weekend, physicians, researchers, diabetes companies and non-profits from all over the world come together for the American Diabetes Association 77th Scientific Sessions. It’s the biggest gathering of the diabetes scientific community all year. But what does it mean for you, someone living with and doing your best to manage your diabetes each day? As […]Read More »
Today, I’m excited to share that we’re rolling out the MiniMed 670G system, beginning with those in the Priority Access program. But before we get into details, on behalf of the entire Medtronic team, I want to extend both my gratitude and my commitment to you. First, thank you for your enthusiasm for this new […]Read More »
At Medtronic, it is in our mission to have an understanding of what our patients go through on a daily basis. One way to foster this type of empathy is for employees to wear our products. This includes everyone from Operations, Research & Development, Sales, Marketing and the leadership team, including Omar Ishrak, CEO of […]Read More »
As we continue our journey to become a holistic diabetes management company, our vision is to transform diabetes care together, for greater freedom and better health. Along this journey, we’re looking at many new and different ways to help people with type 1 and type 2 diabetes. Our newest example of this is an exciting […]Read More »
A few weeks ago, I introduced myself and mentioned my role here at Medtronic Diabetes. In my blog I mentioned that we’re constantly trying to find innovative ways to be there globally for people living with type 1 and type 2 diabetes. One way is through introducing exciting new products to the community, like the […]Read More »
A little over a year ago, Medtronic Diabetes saw the importance of having a role that primarily focused on patients. Someone who would make sure that as a company, we are putting the patient at the forefront of everything we do. This bold move speaks volumes to the dedication the company has at ensuring that […]Read More »